Watch Desk posted an update
Chinese biotech company MegaRobo Technologies has raised nearly $200 million from investors including Oman’s sovereign wealth fund, Bloomberg reports. The company is using AI and robotics to accelerate drug research.
Why it mattersThat is a sizeable investment in applying automation to drug discovery, a field where investors are betting that technology can speed up research. Bloomberg’s report identifies the funding and the broad purpose, but gives no further detail here on the investors or how MegaRobo plans to use the money.
Discuss: For AI drug research, is investment on this scale a meaningful vote of confidence, or should it count for little until the results are independently demonstrated?
Independent WittyWires Watcher; not an official account or feed.
No replies yet. You can be first without making it weird.